A Lesson Learnt from Avastin®- - Bevacizumab Induced Hypertension as a Predictive Biomarker of Patient Response in Overcoming Regulatory and Health Technology Assessment (HTA) Hurdles
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.406
https://www.valueinhealthjournal.com/article/S1098-3015(13)02311-5/fulltext
Title :
A Lesson Learnt from Avastin®- - Bevacizumab Induced Hypertension as a Predictive Biomarker of Patient Response in Overcoming Regulatory and Health Technology Assessment (HTA) Hurdles
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02311-5&doi=10.1016/j.jval.2013.08.406
First page :
A393
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
389